Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | hobatherapeutics.com |
Description | Developing Restorative Treatments for Pain, Hearing Loss, and Sensory Neuron Home Home R & D About Us Media Contact Home R & D About Us Media Contact Mere More child Developing Restorative Treatments for Pain, Hearing Loss, and Sen |
Keywords | N/A |
WebSite | hobatherapeutics.com |
Host IP | 46.30.215.3 |
Location | Denmark |
Site | Rank |
US$3,177,504
Last updated: 2023-05-08 15:29:23
hobatherapeutics.com has Semrush global rank of 3,331,012. hobatherapeutics.com has an estimated worth of US$ 3,177,504, based on its estimated Ads revenue. hobatherapeutics.com receives approximately 366,636 unique visitors each day. Its web server is located in Denmark, with IP address 46.30.215.3. According to SiteAdvisor, hobatherapeutics.com is safe to visit. |
Purchase/Sale Value | US$3,177,504 |
Daily Ads Revenue | US$2,934 |
Monthly Ads Revenue | US$87,993 |
Yearly Ads Revenue | US$1,055,909 |
Daily Unique Visitors | 24,443 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
hobatherapeutics.com. | A | 3599 | IP: 46.30.215.3 |
hobatherapeutics.com. | AAAA | 3600 | IPV6: 2a02:2350:5:104:19:a888:ee78:c759 |
hobatherapeutics.com. | NS | 14400 | NS Record: ns02.one.com. |
hobatherapeutics.com. | NS | 14400 | NS Record: ns01.one.com. |
hobatherapeutics.com. | MX | 3600 | MX Record: 0 hobatherapeutics-com.mail.protection.outlook.com. |
hobatherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
hobatherapeutics.com. | TXT | 3600 | TXT Record: MS=ms75830979 |
Home Home R & D About Us Media Contact Home R & D About Us Media Contact Mere More child Developing Restorative Treatments for Pain, Hearing Loss, and Sensory Neuron Disorders Our Company Hoba Therapeutics was established in 2017 with seed funding from Novo Holdings and Borean Innovation. Our mission is to develop novel biopharmaceuticals for the relief, prevention, and treatment of chronic pain and hearing loss Neuropathic Pain and Hearing Loss More info >> Science Our compounds are first-in-class therapeutic proteins for the treatment of chronic pain and hearing loss. HB-086 and HB-097 are recombinant drug candidates of human Meteorin and human Cometin. This family of proteins have unique therapeutic properties and act on sensory nerve cells and their supporting glia cells. More info >> Our Pipeline HB-086 is in late preclinical development for Neuropathic Pain. Target indications are Chemotherapy-Induced Peripheral Neuropathy (CIPN) and trigeminal neuralgia. HB-097 is |
HTTP/1.1 301 Moved Permanently Date: Sat, 30 Oct 2021 06:57:07 GMT Server: Apache Location: https://hobatherapeutics.com/ Content-Length: 237 Content-Type: text/html; charset=iso-8859-1 X-Varnish: 172364319 Age: 0 Via: 1.1 varnish (Varnish/7.0) Connection: keep-alive HTTP/2 200 date: Sat, 30 Oct 2021 06:57:07 GMT server: Apache last-modified: Fri, 29 Oct 2021 10:50:00 GMT vary: Accept-Encoding content-type: text/html x-varnish: 150087352 age: 0 via: 1.1 varnish (Varnish/7.0) etag: W/"1defa-5cf7b96c450dc-gzip" accept-ranges: bytes |
Domain Name: HOBATHERAPEUTICS.COM Registry Domain ID: 2083596807_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.one.com Registrar URL: http://www.one.com Updated Date: 2020-12-13T05:17:38Z Creation Date: 2016-12-20T21:50:45Z Registry Expiry Date: 2022-12-20T21:50:45Z Registrar: One.com A/S Registrar IANA ID: 1462 Registrar Abuse Contact Email: abuse@one.com Registrar Abuse Contact Phone: +45 44451220 Domain Status: ok https://icann.org/epp#ok Name Server: NS01.ONE.COM Name Server: NS02.ONE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T17:42:04Z <<< |